A Phase 1, Double-blind, Placebo-controlled, Single Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of CPP-115 Solution Administered Orally to Healthy Volunteers

Trial Profile

A Phase 1, Double-blind, Placebo-controlled, Single Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of CPP-115 Solution Administered Orally to Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs CPP 115 (Primary)
  • Indications Infantile spasms
  • Focus Adverse reactions
  • Sponsors Catalyst Pharmaceutical
  • Most Recent Events

    • 22 May 2012 Status changed from active, no longer recruiting to completed.
    • 17 May 2012 Planned End Date changed to 1 Jul 2012, as reported by ClinicalTrials.gov
    • 17 May 2012 New source identified and integrated (ClinicalTrials.gov)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top